Japer Therapeutics, Inc. Warrants (JSPRW)

• Market cap: $1.28M
• 1 day: -1.96%
• 5 days: -1.62%
• 1 month: -22.80%
• 3 months: -31.17%
• 6 months: -61.71%
• Year to date: -61.36%
• 1 year: -55.80%
• 5 years: -86.26%
• 10 years: -90.00%
• Sector: Healthcare
• Industry: Biotechnology

About: Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Employees: 64

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 5 [Q4 2024] → 5 (+0) [Q1 2025]

0.11% less ownership

Funds ownership: 6.18% [Q4 2024] → 6.07% (-0.11%) [Q1 2025]

33% less capital invested

Capital invested by funds: $193K [Q4 2024] → $129K (-$64.1K) [Q1 2025]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3